SCHEMBL6984783

SCHEMBL6984783

NCc1ccc(CCC(=O)N2CCCc3cc(NC(=O)c4ccccc4)ccc32)cc1

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.64
TP53 P04637 3/20 0.56
LMNA P02545 3/20 0.56
ALDH1A1 P00352 1/20 0.53
CREBBP Q92793 3/20 0.50
POLB P06746 2/20 0.50
MAPT P10636 1/20 0.50
NPC1 O15118 1/20 0.48
GAA P10253 1/20 0.48
NFKB1 P19838 1/20 0.48
HTT P42858 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MAPK14 Q16539 1/20 0.47
HSD17B3 P37058 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6984868 0.89 RAB9A (0.60) RAB9ATP53LMNAALDH1A1CREBBP
SCHEMBL6985377 0.89 RAB9A (0.62) RAB9ATP53LMNAALDH1A1CREBBP
SCHEMBL6982229 0.83 NR3C1 (0.60) TP53LMNAMAPTSMN1; SMN2
SCHEMBL6984828 0.82 NR3C1 (0.56) RAB9AALDH1A1CREBBPSMN1; SMN2
SCHEMBL6984787 0.80 ATM (0.48) RAB9ATP53ALDH1A1POLBMAPT
Hydrochloric Acid SCHEMBL6979970 0.78 TMPRSS2 (0.49) RAB9ATP53LMNAALDH1A1POLB
SCHEMBL6981550 0.78 BRD4 (0.57) TP53CREBBPMAPTSMN1; SMN2
SCHEMBL6986003 0.78 RAB9A (0.48) RAB9ATP53ALDH1A1MAPTNPC1
SCHEMBL6982493 0.78 NR3C1 (0.50) CREBBPSMN1; SMN2
SCHEMBL6981023 0.77 RAB9A (0.45) RAB9ATP53LMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed